These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 22441027)

  • 61. Comparison of clinical outcomes of different components of diabetic macular edema on optical coherence tomography.
    Hu Y; Wu Q; Liu B; Cao D; Dong X; Zhang L; Li T; Yang X; Yu H
    Graefes Arch Clin Exp Ophthalmol; 2019 Dec; 257(12):2613-2621. PubMed ID: 31529324
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Influence of pulse pressure and spontaneous variations of macular thickness in patients with diabetic macular oedema.
    Dupas B; Feldman-Billard S; Bui Quoc E; Erginay A; Guillausseau PJ; Massin P
    Acta Ophthalmol; 2014 Aug; 92(5):e372-6. PubMed ID: 24612882
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Optical coherence tomography for evaluating diabetic macular edema before and after vitrectomy.
    Massin P; Duguid G; Erginay A; Haouchine B; Gaudric A
    Am J Ophthalmol; 2003 Feb; 135(2):169-77. PubMed ID: 12566020
    [TBL] [Abstract][Full Text] [Related]  

  • 64. A 12-MONTH, SINGLE-MASKED, RANDOMIZED CONTROLLED STUDY OF EYES WITH PERSISTENT DIABETIC MACULAR EDEMA AFTER MULTIPLE ANTI-VEGF INJECTIONS TO ASSESS THE EFFICACY OF THE DEXAMETHASONE-DELAYED DELIVERY SYSTEM AS AN ADJUNCT TO BEVACIZUMAB COMPARED WITH CONTINUED BEVACIZUMAB MONOTHERAPY.
    Maturi RK; Bleau L; Saunders J; Mubasher M; Stewart MW
    Retina; 2015 Aug; 35(8):1604-14. PubMed ID: 25829346
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Study of aqueous cytokines in patients with different patterns of diabetic macular edema based on optical coherence tomography.
    Bandyopadhyay S; Bandyopadhyay SK; Saha M; Sinha A
    Int Ophthalmol; 2018 Feb; 38(1):241-249. PubMed ID: 28160192
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Visual and Anatomic Outcomes in Patients with Diabetic Macular Edema with Limited Initial Anatomic Response to Ranibizumab in RIDE and RISE.
    Pieramici DJ; Wang PW; Ding B; Gune S
    Ophthalmology; 2016 Jun; 123(6):1345-50. PubMed ID: 26992841
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of ocular pulse amplitude and choroidal thickness in diabetic macular edema.
    Totan Y; Akyüz TK; Güler E; Güragaç FB
    Eye (Lond); 2016 Mar; 30(3):369-74. PubMed ID: 26563658
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Optical coherence tomography for age-related macular degeneration and diabetic macular edema: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(13):1-22. PubMed ID: 23074517
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema.
    Hartley KL; Smiddy WE; Flynn HW; Murray TG
    Retina; 2008 Mar; 28(3):410-9. PubMed ID: 18327132
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of Optical Coherence Tomography Patterns on One-year Outcomes of Aflibercept Therapy for Diabetic Macular Edema.
    Ozcaliskan S; Balci S; Karasu B; Artunay O
    J Coll Physicians Surg Pak; 2020 Feb; 30(2):149-153. PubMed ID: 32036821
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Longer axial length is protective of diabetic retinopathy and macular edema.
    Man RE; Sasongko MB; Sanmugasundram S; Nicolaou T; Jing X; Wang JJ; Wong TY; Lamoureux EL
    Ophthalmology; 2012 Sep; 119(9):1754-9. PubMed ID: 22627119
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Comparison of the magnitude and time course of macular thinning induced by different interventions for diabetic macular edema: implications for sequence of application.
    Browning DJ; Fraser CM; Powers ME
    Ophthalmology; 2006 Oct; 113(10):1713-9. PubMed ID: 16889833
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Diabetic macular edema: correlation between microperimetry and optical coherence tomography findings.
    Vujosevic S; Midena E; Pilotto E; Radin PP; Chiesa L; Cavarzeran F
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3044-51. PubMed ID: 16799051
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Ranibizumab or Aflibercept for Diabetic Macular Edema: Comparison of 1-Year Outcomes from the Fight Retinal Blindness! Registry.
    Bhandari S; Nguyen V; Fraser-Bell S; Mehta H; Viola F; Baudin F; Gabrielle PH; Creuzot-Garcher C; Gillies M; Barthelmes D
    Ophthalmology; 2020 May; 127(5):608-615. PubMed ID: 31932092
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Retinal Layers Changes in Patients with Diabetic Macular Edema Treated with Intravitreal Anti-VEGF Agents: Long-Term Outcomes of a Spectral-Domain OCT Study.
    Chatziralli I; Kazantzis D; Theodossiadis G; Theodossiadis P; Sergentanis TN
    Ophthalmic Res; 2021; 64(2):230-236. PubMed ID: 32564022
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An extension of the Early Treatment Diabetic Retinopathy Study (ETDRS) system for grading of diabetic macular edema in the Astemizole Retinopathy Trial.
    Gardner TW; Sander B; Larsen ML; Kunselman A; Tenhave T; Lund-Andersen H; Reimers J; Hubbard L; Blankenship GW; Quillen DA; Brod RD; Wilmarth MH; Post-Hansen H; Parving HH; Davis MD
    Curr Eye Res; 2006 Jun; 31(6):535-47. PubMed ID: 16769613
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Enhanced depth imaging optical coherence tomography in type 2 diabetes.
    Querques G; Lattanzio R; Querques L; Del Turco C; Forte R; Pierro L; Souied EH; Bandello F
    Invest Ophthalmol Vis Sci; 2012 Sep; 53(10):6017-24. PubMed ID: 22879414
    [TBL] [Abstract][Full Text] [Related]  

  • 78. COMPARING MICROPERIMETRIC AND STRUCTURAL FINDINGS IN PATIENTS WITH BRANCH RETINAL VEIN OCCLUSION AND DIABETIC MACULAR EDEMA.
    Sachdev A; Edington M; Morjaria R; Chong V
    Retina; 2019 Mar; 39(3):446-451. PubMed ID: 29190240
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Association Between Obstructive Sleep Apnea and Diabetic Macular Edema in Patients with Type 2 Diabetes.
    Chiang JF; Sun MH; Chen KJ; Wu WC; Lai CC; Chang CJ; Lin YJ; Chang SC; Huang HY; Chen NH; Li HY
    Am J Ophthalmol; 2021 Jun; 226():217-225. PubMed ID: 33529585
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2.
    Ribeiro L; Bandello F; Tejerina AN; Vujosevic S; Varano M; Egan C; Sivaprasad S; Menon G; Massin P; Verbraak FD; Lund-Andersen H; Martinez JP; Jürgens I; Smets E; Coriat C; Wiedemann P; Ágoas V; Querques G; Holz FG; Nunes S; Neves C; Cunha-Vaz J;
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5698-705. PubMed ID: 26322834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.